A double blind trial of carbenoxolone and geranyl farnesyl acetate in gastric ulcer. 1975

P M Smith, and G E Sladen, and E R Beck, and P N Bennett, and J E Lennard, and J S Langman

57 patients with a chronic gastric ulcer were treated as outpatients in a double blind comparison of carbenozolone 100 mg three times daily with the same dose of geranyl farnesyl acetate (Gefarnate). Healing rates for carbenoxolone were better than for gefarnate, but not significantly so. Nearly half the carbenoxolone-treated patients developed hypokalaemia or oedema, whereas no similar side-effects were found with gefarnate. Gefarnate, while not as effective as carbenoxolone, does appear to promote gastric ulcer healing. Its virtual absence of side-effects makes it a safe and useful drug.

UI MeSH Term Description Entries
D008297 Male Males
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002229 Carbenoxolone An agent derived from licorice root. It is used for the treatment of digestive tract ulcers, especially in the stomach. Antidiuretic side effects are frequent, but otherwise the drug is low in toxicity. Carbenoxalone,18alpha-Carbenoxolone,18alpha-Glycyrrhetinic Acid 3beta-O-Hemisuccinate,Biogastrone,Bioral,Carbeneoxolone,Carbenoxolone Disodium Salt,Carbenoxolone Sodium,Carbosan,Duogastrone,Glycyrrhetinic Acid 3-O-hemisuccinate,Pharmaxolon,Sanodin,18alpha Carbenoxolone,18alpha Glycyrrhetinic Acid 3beta O Hemisuccinate,3-O-hemisuccinate, Glycyrrhetinic Acid,3beta-O-Hemisuccinate, 18alpha-Glycyrrhetinic Acid,Acid 3-O-hemisuccinate, Glycyrrhetinic,Acid 3beta-O-Hemisuccinate, 18alpha-Glycyrrhetinic,Glycyrrhetinic Acid 3 O hemisuccinate
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005231 Fatty Acids, Unsaturated FATTY ACIDS in which the carbon chain contains one or more double or triple carbon-carbon bonds. Fatty Acids, Polyunsaturated,Polyunsaturated Fatty Acid,Unsaturated Fatty Acid,Polyunsaturated Fatty Acids,Acid, Polyunsaturated Fatty,Acid, Unsaturated Fatty,Acids, Polyunsaturated Fatty,Acids, Unsaturated Fatty,Fatty Acid, Polyunsaturated,Fatty Acid, Unsaturated,Unsaturated Fatty Acids
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013276 Stomach Ulcer Ulceration of the GASTRIC MUCOSA due to contact with GASTRIC JUICE. It is often associated with HELICOBACTER PYLORI infection or consumption of nonsteroidal anti-inflammatory drugs (NSAIDS). Gastric Ulcer,Gastric Ulcers,Stomach Ulcers,Ulcer, Gastric,Ulcer, Stomach,Ulcers, Gastric,Ulcers, Stomach
D013729 Terpenes A class of compounds composed of repeating 5-carbon units of HEMITERPENES. Isoprenoid,Terpene,Terpenoid,Isoprenoids,Terpenoids
D014315 Triterpenes A class of terpenes (the general formula C30H48) formed by the condensation of six isoprene units, equivalent to three terpene units. Triterpene,Triterpenoid,Triterpenoids

Related Publications

P M Smith, and G E Sladen, and E R Beck, and P N Bennett, and J E Lennard, and J S Langman
December 1974, International journal of clinical pharmacology, therapy and toxicology,
P M Smith, and G E Sladen, and E R Beck, and P N Bennett, and J E Lennard, and J S Langman
February 1965, Revista brasileira de medicina,
P M Smith, and G E Sladen, and E R Beck, and P N Bennett, and J E Lennard, and J S Langman
April 1968, Revista espanola de las enfermedades del aparato digestivo,
P M Smith, and G E Sladen, and E R Beck, and P N Bennett, and J E Lennard, and J S Langman
February 1978, Annals of clinical research,
P M Smith, and G E Sladen, and E R Beck, and P N Bennett, and J E Lennard, and J S Langman
March 1971, Medizinische Klinik,
P M Smith, and G E Sladen, and E R Beck, and P N Bennett, and J E Lennard, and J S Langman
January 1980, Scandinavian journal of gastroenterology. Supplement,
P M Smith, and G E Sladen, and E R Beck, and P N Bennett, and J E Lennard, and J S Langman
December 1985, Hepato-gastroenterology,
P M Smith, and G E Sladen, and E R Beck, and P N Bennett, and J E Lennard, and J S Langman
February 1970, Gut,
P M Smith, and G E Sladen, and E R Beck, and P N Bennett, and J E Lennard, and J S Langman
May 1972, Munchener medizinische Wochenschrift (1950),
P M Smith, and G E Sladen, and E R Beck, and P N Bennett, and J E Lennard, and J S Langman
March 1964, Il Farmaco; edizione pratica,
Copied contents to your clipboard!